AMGEN Inc. [NASDAQ: AMGN] gained 1.81% on the last trading session, reaching $312.86 price per share at the time.
If compared to the average trading volume of 2.86M shares, AMGN reached a trading volume of 2920516 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about AMGEN Inc. [AMGN]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for AMGN shares is $314.89 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on AMGN stock is a recommendation set at 2.13. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
William Blair have made an estimate for AMGEN Inc. shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on May 03, 2024. While these analysts kept the previous recommendation, Barclays raised their target price from $230 to $300. The new note on the price target was released on May 03, 2024, representing the official price target for AMGEN Inc. stock. On February 07, 2024, analysts decreased their price target for AMGN shares from 324 to 318.
The Average True Range (ATR) for AMGEN Inc. is set at 8.36, with the Price to Sales ratio for AMGN stock in the period of the last 12 months amounting to 5.72. The Price to Book ratio for the last quarter was 33.42, with the Price to Cash per share for the same quarter was set at 18.10. Price to Free Cash Flow for AMGN in the course of the last twelve months was 23.64 with Quick ratio for the last quarter at 0.98.
Trading performance analysis for AMGN stock
AMGEN Inc. [AMGN] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 12.38. With this latest performance, AMGN shares gained by 17.42% in over the last four-week period, additionally plugging by 15.40% over the last 6 months – not to mention a rise of 33.46% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for AMGN stock in for the last two-week period is set at 72.02, with the RSI for the last a single of trading hit 76.02, and the three-weeks RSI is set at 68.03 for AMGEN Inc. [AMGN]. The present Moving Average for the last 50 days of trading for this stock 276.82, while it was recorded at 306.25 for the last single week of trading, and 275.60 for the last 200 days.
AMGEN Inc. [AMGN]: A deeper dive into fundamental analysis
AMGEN Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.98 and a Current Ratio set at 1.42.
AMGEN Inc. [AMGN]: An earnings per share (EPS) analysis
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for AMGN. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for AMGEN Inc. go to 5.72%.
An analysis of Institutional ownership at AMGEN Inc. [AMGN]
The top three institutional holders of AMGN stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.4983%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $200.69 billion in AMGN stocks shares; and BERKSHIRE HATHAWAY INC, currently with $174.35 billion in AMGN stock with ownership which is approximately 5.8386%.
